vigencell hla-b5801
Search results
Scope
Date
~
-
Bio & PharmaViGenCell obtains approval for HLA-B5801 genetic diagnostic kit for adverse reactions to gout treatment
ViGenCell, a company specializing in immunotherapy, announced on Friday that it has obtained approval from the Ministry of Food and Drug Safety (MFD...
Oct 25, 2024 (Gmt+09:00)
-
Bio & PharmaViGenCell, NK/T cell lymphoma treatment ‘VT-EBV-N’ designated as orphan drug in Europe
ViGenCell, a company specializing in immune cell therapy, announced on the 19th that its NK/T cell lymphoma treatment "VT-EBV-N" has been designated...
Dec 27, 2023 (Gmt+09:00)
1
Latest News
- 1 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
- 2 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 3 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 4 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 5 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
